Skip to main content

Advertisement

Log in

Topical diclofenac therapy for osteoarthritis: a meta-analysis of randomized controlled trials

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

The objective of this study was to evaluate the efficacy and safety of topical diclofenac therapy for osteoarthritis (OA). A meta-analysis of randomized controlled trials was conducted. A comprehensive literature search, covering the databases of Medline, the Cochrane Central Register of Controlled Trials, and EMBASE, was conducted in September 2014 to identify the randomized controlled trials which adopted the topical diclofenac therapy for OA. A total of nine papers were included in this meta-analysis. Topical diclofenac appears to be effective in both pain relief (standard mean differences (SMD) = 0.40; 95 % confidence interval (CI) 0.19 to 0.62; P = 0.0003) and function improvement (SMD = 0.23; 95 % CI 0.03 to 0.43; P = 0.03) when compared with the control group. The sensitivity analysis and subgroup analysis showed that the result of pain intensity was stable and reliable, while the result of physical function improvement was vague. With respect to safety, topical diclofenac demonstrated a higher incidence of adverse events such as dry skin, rash, dermatitis, neck pain, and withdrawal. Topical diclofenac is effective in pain relief as a treatment of OA. It may also have a potential effect in function improvement, which needs further studies to be explored. Although, some adverse effects were observed in the application of topical diclofenac, none of them was serious.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Badley EM (1995) The effect of osteoarthritis on disability and health care use in Canada. J Rheumatol Suppl 43:19–22

    CAS  PubMed  Google Scholar 

  2. Peat G, McCarney R, Croft P (2001) Knee pain and osteoarthritis in older adults: a review of community burden and current use of primary health care. Ann Rheum Dis 60(2):91–97

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. (2000) Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum 43:1905–1915. doi:10.1002/1529-0131(200009)43:9<1905::AID-ANR1>3.0.CO;2-P

  4. Jordan KM, Arden NK, Doherty M, Bannwarth B, Bijlsma JW, Dieppe P et al (2003) EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 62(12):1145–1155

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Eccles M, Freemantle N, Mason J (1998) North of England evidence based guideline development project: summary guideline for non-steroidal anti-inflammatory drugs versus basic analgesia in treating the pain of degenerative arthritis. The North of England Non-Steroidal Anti-Inflammatory Drug Guideline Development Group. BMJ 317(7157):526–530

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Mannoni A, Briganti MP, Di Bari M, Ferrucci L, Costanzo S, Serni U, Masotti G, Marchionni N (2003) Epidemiological profile of symptomatic osteoarthritis in older adults: a population based study in Dicomano, Italy. Ann Rheum Dis 62(6):576–578

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Gabriel SE, Jaakkimainen L, Bombardier C (1991) Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med 115(10):787–796

    Article  CAS  PubMed  Google Scholar 

  8. Fries JF (1999) Gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs. N Engl J Med 341(18):1397–1398, 1398-1399

    Article  CAS  PubMed  Google Scholar 

  9. Malemud CJ, Islam N, Haqqi TM (2003) Pathophysiological mechanisms in osteoarthritis lead to novel therapeutic strategies. Cells Tissues Organs 174(1-2):34–48

    Article  PubMed  Google Scholar 

  10. Shimp LA (1998) Safety issues in the pharmacologic management of chronic pain in the elderly. Pharmacotherapy 18(6):1313–1322

    CAS  PubMed  Google Scholar 

  11. Roth SH (1995) A controlled clinical investigation of 3% diclofenac/2.5% sodium hyaluronate topical gel in the treatment of uncontrolled pain in chronic oral NSAID users with osteoarthritis. Int J Tissue React 17(4):129–132

    CAS  PubMed  Google Scholar 

  12. Evans JM, McMahon AD, McGilchrist MM, White G, Murray FE, McDevitt DG, MacDonald TM (1995) Topical non-steroidal anti-inflammatory drugs and admission to hospital for upper gastrointestinal bleeding and perforation: a record linkage case-control study. BMJ 311(6996):22–26

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Moore RA, Tramer MR, Carroll D, Wiffen PJ, McQuay HJ (1998) Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs. BMJ 316(7128):333–338

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Heyneman CA, Lawless-Liday C, Wall GC (2000) Oral versus topical NSAIDs in rheumatic diseases: a comparison. Drugs 60(3):555–574

    Article  CAS  PubMed  Google Scholar 

  15. Pendleton A, Arden N, Dougados M, Doherty M, Bannwarth B, Bijlsma JW et al (2000) EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 59(12):936–944

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Hewitt PG, Poblete N, Wester RC, Maibach HI, Shainhouse JZ (1998) In vitro cutaneous disposition of a topical diclofenac lotion in human skin: effect of a multi-dose regimen. Pharm Res 15(7):988–992

    Article  CAS  PubMed  Google Scholar 

  17. Hui X, Hewitt PG, Poblete N, Maibach HI, Shainhouse JZ, Wester RC (1998) In vivo bioavailability and metabolism of topical diclofenac lotion in human volunteers. Pharm Res 15(10):1589–1595

    Article  CAS  PubMed  Google Scholar 

  18. Tanojo H, Wester RC, Shainhouse JZ, Maibach HI (1999) Diclofenac metabolic profile following in vitro percutaneous absorption through viable human skin. Eur J Drug Metab Pharmacokinet 24(4):345–351

    Article  CAS  PubMed  Google Scholar 

  19. Bookman AA, Williams KS, Shainhouse JZ (2004) Effect of a topical diclofenac solution for relieving symptoms of primary osteoarthritis of the knee: a randomized controlled trial. CMAJ 171(4):333–338

    Article  PubMed  PubMed Central  Google Scholar 

  20. Roth SH, Shainhouse JZ (2004) Efficacy and safety of a topical diclofenac solution (pennsaid) in the treatment of primary osteoarthritis of the knee: a randomized, double-blind, vehicle-controlled clinical trial. Arch Intern Med 164(18):2017–2023

    Article  CAS  PubMed  Google Scholar 

  21. Baer PA, Thomas LM, Shainhouse Z (2005) Treatment of osteoarthritis of the knee with a topical diclofenac solution: a randomised controlled, 6-week trial [ISRCTN53366886]. BMC Musculoskelet Disord 6:44

    Article  PubMed  PubMed Central  Google Scholar 

  22. Bruhlmann P, Michel BA (2003) Topical diclofenac patch in patients with knee osteoarthritis: a randomized, double-blind, controlled clinical trial. Clin Exp Rheumatol 21(2):193–198

    CAS  PubMed  Google Scholar 

  23. Niethard FU, Gold MS, Solomon GS, Liu JM, Unkauf M, Albrecht HH, Elkik F (2005) Efficacy of topical diclofenac diethylamine gel in osteoarthritis of the knee. J Rheumatol 32(12):2384–2392

    CAS  PubMed  Google Scholar 

  24. Simon LS, Grierson LM, Naseer Z, Bookman AA, Zev SJ (2009) Efficacy and safety of topical diclofenac containing dimethyl sulfoxide (DMSO) compared with those of topical placebo, DMSO vehicle and oral diclofenac for knee osteoarthritis. Pain 143(3):238–245

    Article  CAS  PubMed  Google Scholar 

  25. Barthel HR, Haselwood D, Longley SR, Gold MS, Altman RD (2009) Randomized controlled trial of diclofenac sodium gel in knee osteoarthritis. Semin Arthritis Rheum 39(3):203–212

    Article  CAS  PubMed  Google Scholar 

  26. Altman RD, Dreiser RL, Fisher CL, Chase WF, Dreher DS, Zacher J (2009) Diclofenac sodium gel in patients with primary hand osteoarthritis: a randomized, double-blind, placebo-controlled trial. J Rheumatol 36(9):1991–1999

    Article  PubMed  Google Scholar 

  27. Baraf HS, Gold MS, Clark MB, Altman RD (2010) Safety and efficacy of topical diclofenac sodium 1% gel in knee osteoarthritis: a randomized controlled trial. Phys Sportsmed 38(2):19–28

    Article  PubMed  Google Scholar 

  28. Mason L, Moore RA, Edwards JE, Derry S, McQuay HJ (2004) Topical NSAIDs for chronic musculoskeletal pain: systematic review and meta-analysis. BMC Musculoskelet Disord 5:28

    Article  PubMed  PubMed Central  Google Scholar 

  29. Lin J, Zhang W, Jones A, Doherty M (2004) Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomised controlled trials. BMJ 329(7461):324

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Towheed TE (2006) Pennsaid therapy for osteoarthritis of the knee: a systematic review and metaanalysis of randomized controlled trials. J Rheumatol 33(3):567–573

    CAS  PubMed  Google Scholar 

  31. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62(10):e1–e34

    Article  PubMed  Google Scholar 

  32. Higgins JPT, Green S (eds) (2011) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from www.cochrane-handbook.org

  33. Jüni P, Reichenbach S, Dieppe P (2006) Osteoarthritis: rational approach to treating the individual. Best Pract Res Clin Rheumatol 20:721e40

    Article  Google Scholar 

  34. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50(4):1088–1101

    Article  CAS  PubMed  Google Scholar 

  35. Biswal S, Medhi B, Pandhi P (2006) Longterm efficacy of topical nonsteroidal antiinflammatory drugs in knee osteoarthritis: metaanalysis of randomized placebo controlled clinical trials. J Rheumatol 33(9):1841–1844

    CAS  PubMed  Google Scholar 

  36. Puenpatom RA, Victor TW (2009) Increased prevalence of metabolic syndrome in individuals with osteoarthritis: an analysis of NHANES III data. Postgrad Med 121(6):9–20

    Article  PubMed  Google Scholar 

  37. Singh G, Fort JG, Goldstein JL, Levy RA, Hanrahan PS, Bello AE et al (2006) Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study. Am J Med 119(3):255–266

    Article  CAS  PubMed  Google Scholar 

  38. Stricker K, Yu S, Krammer G (2008) A 6-week, multicentre, randomised, double-blind, double-dummy, active-controlled, clinical safety study of lumiracoxib and rofecoxib in osteoarthritis patients. BMC Musculoskelet Disord 9:118

    Article  PubMed  PubMed Central  Google Scholar 

  39. Berner G, Engels B, Vogtle-Junkert U (1989) Percutaneous ibuprofen therapy with Trauma-Dolgit gel: bioequivalence studies. Drugs Exp Clin Res 15(11-12):559–564

    CAS  PubMed  Google Scholar 

  40. Vanderstraeten G, Schuermans P (1990) Study on the effect of etofenamate 10% cream in comparison with an oral NSAID in strains and sprains due to sports injuries. Acta Belg Med Phys 13(3):139–141

    CAS  PubMed  Google Scholar 

  41. Egger M, Zellweger-Zahner T, Schneider M, Junker C, Lengeler C, Antes G (1997) Language bias in randomised controlled trials published in English and German. Lancet 350(9074):326–329

    Article  CAS  PubMed  Google Scholar 

Download references

Contributors

Guang-hua Lei, Zhen-han Deng, and Chao Zeng selected the studies. Guang-hua Lei wrote the manuscript. Zhen-han Deng and Chao Zeng helped in writing the manuscript. Ye Yang, Yu-sheng Li, Jie Wei, Tuo Yang, and Hui Li reviewed the manuscript. All authors contributed to the design of the study.

Funding

This work was supported by the Fundamental Research Funds for the Central Universities of Central South University (2014zzts347), the Hunan Provincial Innovation Foundation for Postgraduate (CX2014A005), the National Natural Science Foundation of China (Nos. 81201420, 81272034, 81472130), the Provincial Science Foundation of Hunan (No. 14JJ3032), the Scientific Research Project of the Development and Reform Commission of Hunan Province ([2013]1199), the Scientific Research Project of Science and Technology Office of Hunan Province (2013SK2018), and the Doctoral Scientific Fund Project of the Ministry of Education of China (20120162110036).

Disclosures

None.

Data sharing statement

No additional data are available.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Guang-hua Lei.

Additional information

Zhen-han Deng and Chao Zeng contributed equally to this work.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(DOCX 15 kb)

ESM 2

(DOCX 150 kb)

ESM 3

(DOC 39 kb)

ESM 4

(DOCX 179 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Deng, Zh., Zeng, C., Yang, Y. et al. Topical diclofenac therapy for osteoarthritis: a meta-analysis of randomized controlled trials. Clin Rheumatol 35, 1253–1261 (2016). https://doi.org/10.1007/s10067-015-3021-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-015-3021-z

Keywords

Navigation